Professor Jacqueline Matthews, Chief Technology Officer, Roslin Technologies Limited has joined the board at Vetsina Animal Diagnostics Ltd as a non-executive director. She replaces Glen Illing who has stepped down.
Vetsina CEO, Dr. Simon Wheeler, said: “We are grateful to Glen Illing for his support while we established Vetsina and thank him for his contributions at the early stages of the company. We are excited to now be able to welcome Professor Matthews to the board as we move on with Vetsina’s development. Professor Matthews’ experience and skills are highly relevant to the work we are doing in developing innovative diagnostics for animal health and veterinary use.”
A qualified veterinarian, Professor Matthews has worked in animal health for over 30 years. Until 2019, she was based in academia, where she led research programmes supported by more than £13 million of competitive funding. These projects had wide industry impact relating to livestock infectious disease and generated more than 140 associated peer-reviewed publications and many lay articles.
During this period, she developed, from first principles, a diagnostic test for small redworm in horses, which was commercialised in 2019. In 2017, she was awarded Royal College of Veterinary Surgeons (RCVS) Fellowship and Elsevier’s International Journal for Parasitology Award. Professor Matthews is a RCVS Recognised Specialist (Parasitology) and Honorary Professor at the Royal (Dick) School of Veterinary Studies and currently has a ministerial appointment on the UK Veterinary Products Committee and sits on two UKRI BBSRC Committees.
In 2019, she moved to Roslin Technologies, where she leads on Strategic Partnerships and manages the R&D programme, bringing scientific innovations to the agri and animal health sectors. She has a strong commercial awareness, combined with a long track record in translational science, project development, Board & Committee engagement, and public speaking.
ends
Editor’s notes:
About Vetsina Animal Diagnostics
Vetsina Animal Diagnostics has been established to maximise the impact of a revolutionary chemical-based system for detecting nucleic acids and single nucleotide polymorphisms, for the development of simple, fast, accurate & cost-effective products for PCR-free detection of microRNAs in human medicine, by applying it to animal health.
Vetsina will also research the animal diagnostics arena to focus on targets based on market need, technical feasibility and the development of a balanced portfolio.
It was founded by Roslin Technologies and DESTINA Genomics.
About Roslin Technologies
Roslin Technologies is a technology commercialisation company based at Easter Bush Campus, at the centre of the largest concentration of animal science expertise in Europe. The company was created to develop commercial opportunities from the research, know-how, capabilities and intellectual property of The Roslin Institute and The Royal (Dick) School of Veterinary Studies.
Roslin Technologies develop and supply products and services to industry, as well as providing opportunities for investors looking to capitalise on the growing demand for food and agricultural products. For additional information, visit www.roslintech.com.
About DESTINA Genomics
DESTINA Genomics Ltd is a biotech company founded in Edinburgh in 2011 by Hugh Ilyine, Juan J. Diaz-Mochon and Mark Bradley. In July 2012, a Spanish subsidiary DESTINA Genomica S.L. was created with the goal to accelerate a long-term growth plan. The company is focused on the application and validation of its patented state-of-the-art technologies. For additional information, visit https://DESTINAgenomics.com/
For more information contact Mike Keeler (mike.keeler@garnettkeeler.com) or Alistair Moses
(alistair.moses@garnettkeeler.com) at Garnett Keeler PR on +44 (0)20 8647 4467.
VAD/007/20
